G9a inhibits MEF2C activity to control sarcomere assembly

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Ow, Jin Rong ^a,b   Palanichamy Kala, Monica ^a   Rao, Vinay Kumar ^a   Choi, Min Hee ^a,b   Bharathy, Narendra ^a   Taneja, Reshma ^a,b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84989266627     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep34163     Document Type: Article

References (58)

1. Molkentin, J. D., Black, B. L., Martin, J. F. & Olson, E. N. Cooperative activation of muscle gene expression by MEF2 and myogenic bHLH proteins. Cell 83, 1125-1136 (1995).
2. Kaushal, S., Schneider, J. W., Nadal-Ginard, B. & Mahdavi, V. Activation of the myogenic lineage by MEF2A, a factor that induces and cooperates with MyoD. Science 266, 1236-1240 (1994).
3. Black, B. L. & Olson, E. N. Transcriptional control of muscle development by myocyte enhancer factor-2 (MEF2) proteins. Annu. Rev. Cell Dev. Biol. 14, 167-196 (1998).
4. Shore, P. & Sharrocks, A. D. The MADS-box family of transcription factors. Eur. J. Biochem. 229, 1-13 (1995).
5. Molkentin, J. D., Black, B. L., Martin, J. F. & Olson, E. N. Mutational analysis of the DNA binding, dimerization, and transcriptional activation domains of MEF2C. Mol. Cell. Biol. 16, 2627-2636 (1996).
6. Lu, J., McKinsey, T. A., Zhang, C. L. & Olson, E. N. Regulation of skeletal myogenesis by association of the MEF2 transcription factor with class II histone deacetylases. Mol. Cell 6, 233-244 (2000).
7. Fischle, W. et al. Enzymatic activity associated with class II HDACs is dependent on a multiprotein complex containing HDAC3 and SMRT/N-CoR. Mol. Cell 9, 45-57 (2002).
8. Zhang, C. L., McKinsey, T. A. & Olson, E. N. Association of class II histone deacetylases with heterochromatin protein 1: potential role for histone methylation in control of muscle differentiation. Mol. Cell. Biol. 22, 7302-7312 (2002).
9. Lu, J., McKinsey, T. A., Nicol, R. L. & Olson, E. N. Signal-dependent activation of the MEF2 transcription factor by dissociation from histone deacetylases. Proc. Natl. Acad. Sci. USA 97, 4070-4075 (2000).
10. McKinsey, T. A., Zhang, C. L. & Olson, E. N. Activation of the myocyte enhancer factor-2 transcription factor by calcium/ calmodulin-dependent protein kinase-stimulated binding of 14-3-3 to histone deacetylase 5. Proc. Natl. Acad. Sci. USA 97, 14400-14405 (2000).
11. Vega, R. B. et al. Protein kinases C and D mediate agonist-dependent cardiac hypertrophy through nuclear export of histone deacetylase 5. Mol. Cell. Biol. 24, 8374-8385 (2004).
12. Dequiedt, F. et al. New role for hPar-1 kinases EMK and C-TAK1 in regulating localization and activity of class IIa histone deacetylases. Mol. Cell. Biol. 26, 7086-7102 (2006).
13. Han, J., Jiang, Y., Li, Z., Kravchenko, V. V. & Ulevitch, R. J. Activation of the transcription factor MEF2C by the MAP kinase p38 in inflammation. Nature 386, 296-299 (1997).
14. Kato, Y. et al. BMK1/ERK5 regulates serum-induced early gene expression through transcription factor MEF2C. EMBO J. 16, 7054-7066 (1997).
15. Sartorelli, V., Huang, J., Hamamori, Y. & Kedes, L. Molecular mechanisms of myogenic coactivation by p300: direct interaction with the activation domain of MyoD and with the MADS box of MEF2C. Mol. Cell. Biol. 17, 1010-1026 (1997).
16. Youn, H. D., Grozinger, C. M. & Liu, J. O. Calcium regulates transcriptional repression of myocyte enhancer factor 2 by histone deacetylase 4. J. Biol. Chem. 275, 22563-22567 (2000).
17. Lilly, B. et al. Requirement of MADS domain transcription factor D-MEF2 for muscle formation in Drosophila. Science 267, 688-693 (1995).
18. Bour, B. A. et al. Drosophila MEF2, a transcription factor that is essential for myogenesis. Genes Dev. 9, 730-741 (1995).
19. Edmondson, D. G., Lyons, G. E., Martin, J. F. & Olson, E. N. Mef2 gene expression marks the cardiac and skeletal muscle lineages during mouse embryogenesis. Dev. 120, 1251-1263 (1994).
20. Potthoff, M. J. et al. Regulation of skeletal muscle sarcomere integrity and postnatal muscle function by Mef2c. Mol. Cell. Biol. 27, 8143-8151 (2007).
21. Hinits, Y. & Hughes, S. M. Mef2s are required for thick filament formation in nascent muscle fibres. Dev. 134, 2511-2519 (2007).
22. Potthoff, M. J. et al. Histone deacetylase degradation and MEF2 activation promote the formation of slow-twitch myofibers. J. Clin. Invest. 117, 2459-2467 (2007).
23. Cohen, T. J. et al. HDAC4 regulates muscle fiber type-specific gene expression programs. Mol. Cells 38, 343-348 (2015).
24. Cohen, T. J. et al. The deacetylase HDAC4 controls myocyte enhancing factor-2-dependent structural gene expression in response to neural activity. FASEB J. 23, 99-106 (2009).
25. Rokach, O. et al. Epigenetic changes as a common trigger of muscle weakness in congenital myopathies. Hum. Mol. Genet. 24, 4636-4647 (2015).
26. Cenik, B. K. et al. Severe myopathy in mice lacking the MEF2/SRF-dependent gene leiomodin-3. J. Clin. Invest. 125, 1569-1578 (2015).
27. Shankar, S. R. et al. G9a, a multipotent regulator of gene expression. Epigenetics 8, 16-22 (2013).
28. Shinkai, Y. & Tachibana, M. H3K9 methyltransferase G9a and the related molecule GLP. Genes Dev. 25, 781-788 (2011).
29. Mozzetta, C., Pontis, J. & Ait-Si-Ali, S. Functional Crosstalk Between Lysine Methyltransferases on Histone Substrates: The Case of G9A/GLP and Polycomb Repressive Complex 2. Antioxid. Redox Signal. 22, 1365-1381 (2015).
30. Tachibana, M. et al. G9a histone methyltransferase plays a dominant role in euchromatic histone H3 lysine 9 methylation and is essential for early embryogenesis. Genes Dev. 16, 1779-1791 (2002).
31. Schaefer, A. et al. Control of cognition and adaptive behavior by the GLP/G9a epigenetic suppressor complex. Neuron 64, 678-691 (2009).
32. Ling, B. M. T. et al. Lysine methyltransferase G9a methylates the transcription factor MyoD and regulates skeletal muscle differentiation. Proc. Natl. Acad. Sci. USA 109, 841-846 (2012).
33. Choi, J. et al. Modulation of lysine methylation in myocyte enhancer factor 2 during skeletal muscle cell differentiation. Nucleic Acids Res. 42, 224-234 (2014).
34. Rao, V. K. et al. G9a promotes proliferation and inhibits cell cycle exit during myogenic differentiation. Nucleic Acids Res. doi: 10.1093/nar/gkw483 (2016).
35. Vedadi, M. et al. A chemical probe selectively inhibits G9a and GLP methyltransferase activity in cells. Nat. Chem. Biol. 7, 566-574 (2011).
36. Wang, H. et al. NF-kappaB mediates the transcription of mouse calsarcin-1 gene, but not calsarcin-2, in C2C12 cells. BMC Mol. Biol. 8, 19 (2007).
37. Miska, E. A. et al. Differential localization of HDAC4 orchestrates muscle differentiation. Nucleic Acids Res. 29, 3439-3447 (2001).
38. McKinsey, T. A., Zhang, C. L., Lu, J. & Olson, E. N. Signal-dependent nuclear export of a histone deacetylase regulates muscle differentiation. Nature 408, 106-111 (2000).
39. Battisti, V. et al. Unexpected distinct roles of the related histone H3 lysine 9 methyltransferases G9a and G9a-Like Protein in myoblasts. J. Mol. Biol. 428, 2329-2343 (2016).
40. Estrella, N. L. & Naya, F. J. Transcriptional networks regulating the costamere, sarcomere, and other cytoskeletal structures in striated muscle. Cell. Mol. Life Sci. 71, 1641-1656 (2014).
41. Shi, Y. et al. Coordinated histone modifications mediated by a CtBP co-repressor complex. Nature 422, 735-738 (2003).
42. Fritsch, L. et al. A subset of the histone H3 lysine 9 methyltransferases Suv39h1, G9a, GLP, and SETDB1 participate in a multimeric complex. Mol. Cell 37, 46-56 (2010).
43. Ha, C. H. et al. PKA phosphorylates histone deacetylase 5 and prevents its nuclear export, leading to the inhibition of gene transcription and cardiomyocyte hypertrophy. Proc. Natl. Acad. Sci. USA 107, 15467-15472 (2010).
44. Klamut, H. J., Bosnoyan-Collins, L. O., Worton, R. G. & Ray, P. N. A muscle-specific enhancer within intron 1 of the human dystrophin gene is functionally dependent on single MEF-1/E box and MEF-2/AT-rich sequence motifs. Nucleic Acids Res. 25, 1618-1625 (1997).
45. Oh, S. Y. et al. The Histone Methyltransferase Inhibitor BIX01294 Inhibits HIF-1α Stability and Angiogenesis. Mol. Cells 38, 528-534 (2015).
46. Chen, X., El Gazzar, M., Yoza, B. K. & McCall, C. E. The NF-kappaB factor RelB and histone H3 lysine methyltransferase G9a directly interact to generate epigenetic silencing in endotoxin tolerance. J. Biol. Chem. 284, 27857-27865 (2009).
47. Han, P. et al. Epigenetic response to environmental stress: Assembly of BRG1-G9a/GLP-DNMT3 repressive chromatin complex on Myh6 promoter in pathologically stressed hearts. Biochim. Biophys. Acta doi: 10.1016/j.bbamcr.2016.03.002 (2016).
48. Siegert, R. et al. A myomesin mutation associated with hypertrophic cardiomyopathy deteriorates dimerisation properties. Biochem. Biophys. Res. Commun. 405, 473-479 (2011).
49. Chiu, C. et al. Mutations in alpha-actinin-2 cause hypertrophic cardiomyopathy: a genome-wide analysis. J. Am. Coll. Cardiol. 55, 1127-1135 (2010).
50. Osio, A. et al. Myozenin 2 is a novel gene for human hypertrophic cardiomyopathy. Circ. Res. 100, 766-768 (2007).
51. Frey, N. et al. Mice lacking calsarcin-1 are sensitized to calcineurin signaling and show accelerated cardiomyopathy in response to pathological biomechanical stress. Nat. Med. 10, 1336-1343 (2004).
52. Chen, G. et al. H3K9 histone methyltransferase G9a ameliorates dilated cardiomyopathy via the downregulation of cell adhesion molecules. Mol. Med. Rep. 11, 3872-3879 (2015).
53. van Oort, R. J. et al. MEF2 activates a genetic program promoting chamber dilation and contractile dysfunction in calcineurininduced heart failure. Circulation 114, 298-308 (2006).
54. Xu, J. et al. Myocyte enhancer factors 2A and 2C induce dilated cardiomyopathy in transgenic mice. J. Biol. Chem. 281, 9152-9162 (2006).
55. Sun, H. et al. Stra13 regulates satellite cell activation by antagonizing Notch signaling. J. Cell Biol. 177, 647-657 (2007).
56. Nishio, H. & Walsh, M. J. CCAAT displacement protein/cut homolog recruits G9a histone lysine methyltransferase to repress transcription. Proc. Natl. Acad. Sci. USA 101, 11257-11262 (2004).
57. Shen, H. et al. The Notch coactivator, MAML1, functions as a novel coactivator for MEF2C-mediated transcription and is required for normal myogenesis. Genes Dev. 20, 675-688 (2006).
58. Wang, X., Spandidos, A., Wang, H. & Seed, B. PrimerBank: a PCR primer database for quantitative gene expression analysis, 2012 update. Nucleic Acids Res. 40, D1144-D1149 (2012).